The three-day conference is expected to bring together more than 3,000 physiotherapists, clinicians, researchers, academicians, and students
The collaboration will establish the MUMPMP–Agilent BioDiscovery Hub
Sotyktu continues to demonstrate consistent efficacy and safety across rheumatic conditions
Dr. Brown brings extensive international experience in oncology and radiopharmaceutical development,
Enpatoran is a potential first-in-class oral therapy for CLE and SLE that is thought to selectively block the activation of Toll-like receptors (TLR)7 and TLR8
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
